
Redefining Healthcare
Through Innovation
and Partnerships.
End-to-end WHO-GMP certified pharmaceutical solutions built on quality. We combine scientific innovation with premium third-party manufacturing and exclusive PCD franchises, trusted worldwide.
Manufacturing
Every Time
CHOOSE YOUR PARTNERSHIP PATH

I Am a Global Client

Third Party Manufacturing

Contract Manufacturing for Pets

Government Supply Channel

Premium Pet Health Brands

BA/BE Studies

Clinical Trials

Medical Writing

Regulatory Affairs
Explore More Opportunities
Partners in Process, Our Franchise Products
A curated network of trusted PCD partners delivering Celesta-quality solutions to their communities across India and beyond.
Join Celesta's Franchise Network
Monopoly rights · Full marketing support · 3,000+ product range · Same day dispatch
Why ChooseCelesta?
With science at our core and quality in every step, we deliver healthcare solutions that improve lives around the globe.
Know More About UsOur Production Facilities
State-of-the-art manufacturing facilities built with cutting-edge technology to deliver uncompromised quality at every step.
Our Partner Manufacturing Units
A strong network of WHO-GMP certified partner manufacturing plants ensuring scale, quality, and compliance across all operations.
Frequently Asked Questions
1. What certifications does your manufacturing facility hold?
3. What therapeutic segments do you manufacture?
5. How quickly can you process and dispatch orders?
7. Do you export products internationally?
2. Do you offer monopoly rights for PCD franchises?
4. What is the minimum order quantity (MOQ) for third-party manufacturing?
6. Can I get customized packaging for my brand?
8. Do you offer BA/BE studies and clinical research services?
Read Our Informative Articles
Learn about our latest pharmaceutical innovations, health guidelines, and industry insights from Celesta Healthcare experts.
New Drugs and Clinical Trials Rules 2019, Explained for Sponsors
A sponsor's guide to the New Drugs and Clinical Trials Rules 2019: timelines, deemed approval, ethics committee rules, compensation duties and filing tips.
ICH E3 Clinical Study Report Structure: A Section-by-Section Guide
A section-by-section walkthrough of the ICH E3 clinical study report: what each of the 16 sections must contain and what regulatory reviewers look for.
BA/BE Studies in India: CDSCO Requirements, Process & Timelines (2026 Guide)
How CDSCO regulates BA/BE studies in India: when bioequivalence is mandatory, the BE NOC export route, NDCT 2019 forms and realistic approval timelines.
Ready to Partner with Celesta?
Whether you're looking for a PCD franchise, contract manufacturing, or global pharmaceutical exports — we have tailored solutions for your business.

